Table 1 summarizes the adverse effects associated with enfuvirtide. Enfuvirtide's safety at 48 weeks was recently reported by Eron et al. [18] The most common adverse effects of any severity ...

M. Christine Jamjian, Pharm.D., was, when this article was written, Clinical Pharmacist, Positive Health Program, and Assistant Clinical Professor, School of Pharmacy ...

fusion oncogene and tested for its sensitivity to inhibitors of ALK. We employed the CRISPR/Cas9 genome editing platform for the generation of the desired targeted genomic rearrangement in the ...

We have developed a convenient reporter system by producing N-end rule and ubiquitin fusion degradation (UFD ... in cells treated with proteasome inhibitors. Comparison of reporter accumulation ...

A fourth of patients with TRK fusion primary central nervous system tumors responded to the TRK inhibitor larotrectinib ...